|
Laska, E M; Meisner, M; Siegel, C et al. (2001) Statistical cost-effectiveness analysis of two treatments based on net health benefits. Stat Med 20:1279-302
|
|
Laska, E M; Meisner, M; Siegel, C (1999) Power and sample size in cost-effectiveness analysis. Med Decis Making 19:339-43
|
|
Laska, E M; Meisner, M; Siegel, C et al. (1999) Ratio-based and net benefit-based approaches to health care resource allocation: proofs of optimality and equivalence. Health Econ 8:171-4
|
|
Laska, E M; Meisner, M; Siegel, C (1997) Statistical inference for cost-effectiveness ratios. Health Econ 6:229-42
|
|
Laska, E M; Meisner, M; Siegel, C (1997) The usefulness of average cost-effective ratios. Health Econ 6:497-504
|
|
Laska, E M; Meisner, M; Tang, D I (1997) Classification of the effectiveness of combination treatments. Stat Med 16:2211-28
|
|
Czobor, P; Volavka, J (1996) Dimensions of the Brief Psychiatric Rating Scale: an examination of stability during haloperidol treatment. Compr Psychiatry 37:205-15
|
|
Siegel, C; Laska, E; Meisner, M (1996) Statistical methods for cost-effectiveness analyses. Control Clin Trials 17:387-406
|
|
Wolkin, A; Sanfilipo, M; Duncan, E et al. (1996) Blunted change in cerebral glucose utilization after haloperidol treatment in schizophrenic patients with prominent negative symptoms. Am J Psychiatry 153:346-54
|
|
Czobor, P; Volavka, J (1996) Positive and negative symptoms: is their change related? Schizophr Bull 22:577-90
|
Showing the most recent 10 out of 23 publications
